Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Clinical Development

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1790684

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1790684

Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030

PUBLISHED:
PAGES: 446 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The mice model market is projected to reach USD 2.74 billion by 2030 from USD 1.70 billion in 2025, at a CAGR of 10.0% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsModel Type & Service, Technology, Therapeutic Area, Application, Product End User, Services End User, and Region
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa

The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials (MCTs); the rising demand for personalized medicine in oncology; and advancements in genetic engineering. Utilization of CRISPR in biomedical research and the increasing demand for disease-specific models are also expected to contribute to market growth during the forecast period.

Mice Model Market - IMG1

By model type, the inbred mice segment accounted for the largest share of the market in 2024.

The market is segmented by model type into inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice. In 2024, the inbred mice segment accounted for the largest share of the mice model market. The large share of the inbred mice segment is attributed to the ability of inbred strains to provide genetic uniformity for preclinical studies, standardized breeding protocols that enable scalable production, and supply chains that support continuous availability. Regulatory frameworks at national and international levels recognize inbred strains as reference models for efficacy and safety assessment, and centralized breeding facilities implement quality control measures to maintain strain integrity. Adoption of inbred mice spans pharmaceutical and biotechnology companies and academic and government research institutions, where controlled genetic backgrounds reduce experimental variability.

By application, the drug discovery & development segment accounted for the largest share of the market in 2024.

The mice model market is segmented into drug discovery & development, research applications, and personalized medicine. In 2024, the drug discovery & development segment accounted for the largest share of the market. Mouse models are deployed in target validation assays to confirm the relevance of molecular targets, in lead optimization studies to compare pharmacodynamic profiles, and in efficacy evaluations to measure treatment responses under controlled conditions. Safety pharmacology protocols-cardiovascular, respiratory, and central nervous system endpoints-rely on telemetry recordings and behavioral assays conducted in mice. At the same time, reproductive and developmental toxicity assessments use timed-pregnancy protocols to determine embryonic viability and teratogenic risk. Histopathological examinations and clinical chemistry analyses of tissue samples support regulatory submissions, and omics profiling (transcriptomics, proteomics, metabolomics) informs dose selection and mechanism-of-action studies. Service providers integrate these applications into end-to-end workflows for end users. Combined, these integrated applications ensure the dominance of drug discovery & development applications in the mice model market.

By region, North America accounted for the largest share of the mice model market in 2024.

In 2024, North America accounted for the largest share of the mice model market due to the concentration of major contract research organizations and breeding suppliers, government and private funding mechanisms, and a regulatory environment emphasizing standardized preclinical practices. The key market players, such as Charles River Laboratories (US), The Jackson Laboratory (US), and Inotiv (US), have their presence in the region, thus ensuring regional supply and technical support. Public funding agencies such as the National Institutes of Health (NIH) allocate substantial budgets to basic & translational research, while pharmaceutical & biotechnology companies commit a significant portion of R&D expenditure to preclinical in vivo models. Academic research institutions and specialized contract research organizations leverage this infrastructure and funding landscape to conduct target validation, toxicology, and efficacy studies, reinforcing North America's large share in the global mice model market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Tier 1-25%, Tier 2-35%, and Tier 3- 40%
  • By Designation: C-level Executives - 55%, Directors- 20%, and Others- 25%
  • By Region: North America -45%, Europe - 20%, the Asia Pacific -20%, Latin America -10%, the Middle East- 3%, and Africa-2%

Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), Biocytogen (China), TRANS GENIC INC. (Japan) Harbour BioMed (China), genOway (France), GemPharmatech (China), Cyagen (US), Ozgene Pty Ltd (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Vivo Bio Tech Ltd (India), ingenious targeting laboratory (US), Janvier Labs (France), Champions Oncology, Inc (US), and Vitalstar Biotechnology Co., Ltd. (China) are some of the key companies offering mice model products & services.

Research Coverage:

This research report categorizes the mice model market by model type & service [model types (inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice, breeding services, cryopreservation services, rederivation services, quarantine services, and other services)], by application (drug discovery & development, research applications, and personalized medicine), by technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), by therapeutic area (oncology, neurology, immunology, metabolic diseases, cardiovascular diseases, and other therapeutic areas), by product end user (pharmaceutical & biotechnology companies, academic & research Institutes, and CROs & CDMOs), by services end user (pharmaceutical & biotechnology companies, government & biomedical research institutes, and CDMOs), and by region (North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa).

The report's scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the mice model market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product & service launches, acquisitions, and recent developments associated with the mice model market. This report covers the competitive analysis of upcoming startups in the mice model market ecosystem.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the mice model market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following :

  • Analysis of key drivers (high adoption of mice models in preclinical studies, the increasing demand for mouse clinical trials, the rising demand for personalized medicine in oncology, technological advancements in genetic engineering), restrains (the introduction of 3D printed models, ethical concerns, and regulatory restrictions), opportunities (Utilization of CRISPR in biomedical research, and the rising demand for disease-specific models), and challenges (development of alternative animal testing methods and genetic & phenotypic variability).
  • Product approvals: Detailed insights into newly approved products of the mice models market.
  • Market development: Comprehensive information about lucrative markets - the report analyses the mice model market across varied regions.
  • Market diversification: Exhaustive information about new products, recent developments, and investments in the mice model market.
  • Pipeline analysis: Comprehensive information about products under clinical trials.
  • Competitive assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), and Biocytogen (China).
Show more
Product Code: BT 2192

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 INCLUSIONS & EXCLUSIONS
    • 1.3.2 MARKETS & REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
  • 2.3 TOP-DOWN APPROACH
  • 2.4 GROWTH FORECAST
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 LIMITATIONS
  • 2.8 MARKET FORECAST
  • 2.9 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 MICE MODEL MARKET OVERVIEW
  • 4.2 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE (2024)
  • 4.3 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 MICE MODEL MARKET, BY MODEL TYPE (END USER), 2025 VS. 2030
  • 4.5 MICE MODEL MARKET SHARE, BY SERVICES (END USER)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High adoption of mice models in preclinical studies
      • 5.2.1.2 Increasing demand for Mouse Clinical Trials (MCTs)
      • 5.2.1.3 Growing preference for personalized medicine in oncology
      • 5.2.1.4 Advancements in genetic engineering
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Introduction of 3D printed models
      • 5.2.2.2 Ethical concerns and regulatory restrictions
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Utilization of CRISPR in biomedical research
      • 5.2.3.2 Rising demand for disease-specific models
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Development of alternative animal testing methods
      • 5.2.4.2 Genetic & phenotypic variability
  • 5.3 MICE MODEL MARKET LANDSCAPE
    • 5.3.1 HISTORY OF MICE MODELS
    • 5.3.2 MICE MODEL GENERATION PROCESS
    • 5.3.3 TECHNIQUES FOR MICE MODEL DEVELOPMENT
    • 5.3.4 TECHNOLOGICAL ADVANCEMENTS
    • 5.3.5 CONSIDERATIONS FOR MICE MODEL DEVELOPMENT
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022-2024
    • 5.5.2 AVERAGE SELLING PRICE OF MODEL TYPES, BY REGION, 2024
  • 5.6 ECOSYSTEM ANALYSIS
    • 5.6.1 MICE MODEL VENDORS
    • 5.6.2 MICE MODEL SERVICE VENDORS
    • 5.6.3 MICE MODEL END USERS
    • 5.6.4 REGULATORY ORGANIZATIONS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 CRISPR/CAS9 gene editing
      • 5.7.1.2 Pronuclear Microinjection (PNI)
      • 5.7.1.3 Embryo cryopreservation & assisted reproduction
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 Multimodal preclinical imaging
      • 5.7.2.2 Automated behavioural phenotyping
      • 5.7.2.3 Integrated physiological monitoring
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Ex vivo CRISPR screening in cell culture
      • 5.7.3.2 High-content bioinformatics pipeline
      • 5.7.3.3 Mass spectroscopy-based tissue profiling
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 PATENT ANALYSIS
    • 5.9.1 METHODOLOGY
    • 5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • 5.10 TRADE DATA ANALYSIS
    • 5.10.1 IMPORT DATA
    • 5.10.2 IMPORT DATA
  • 5.11 KEY CONFERENCES & EVENTS
    • 5.11.1 KEY CONFERENCES & EVENTS (2025-2026)
  • 5.12 TARIFF & REGULATORY LANDSCAPE
    • 5.12.1 TARIFF DATA (HS CODE 106.19.90)
    • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.12.3 REGULATORY FRAMEWORK
      • 5.12.3.1 North America
      • 5.12.3.2 Europe
      • 5.12.3.3 China
      • 5.12.3.4 Japan
      • 5.12.3.5 India
      • 5.12.3.6 Australia
      • 5.12.3.7 Brazil
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
    • 5.14.3 BUYING CRITERIA FOR MICE MODEL MARKET
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF GENERATIVE AI ON MICE MODEL MARKET
    • 5.16.1 AI-USE CASES
    • 5.16.2 KEY COMPANIES IMPLEMENTING AI
  • 5.17 CASE STUDIES
    • 5.17.1 CASE STUDY 1: AAV GENE EDITING IN CYAGEN LDLR MUTANT MICE AMELIORATES ATHEROSCLEROSIS
    • 5.17.2 CASE STUDY 2: METABOLIC EFFECTS OF SEMAGLUTIDE & TIRZEPATIDE IN DIET-INDUCED OBESE (DIO) MICEBAC
    • 5.17.3 CASE STUDY 3: TARGETING NATURAL KILLER CELL ACTIVITY WITH HUMANIZED NSG-IL15 MOUSE MODEL
  • 5.18 TRUMP TARIFF IMPACT ON MICE MODEL MARKET
    • 5.18.1 KEY TARIFF RATES
    • 5.18.2 PRICE IMPACT ANALYSIS
    • 5.18.3 KEY IMPACT ON VARIOUS REGIONS
      • 5.18.3.1 US
      • 5.18.3.2 Europe
      • 5.18.3.3 Asia Pacific
      • 5.18.3.4 Rest of the World
    • 5.18.4 END-USE INDUSTRY IMPACT
      • 5.18.4.1 Pharmaceutical & biotechnology companies
      • 5.18.4.2 CROs & CDMOs
      • 5.18.4.3 Academic & research institutes

6 MICE MODEL MARKET, BY MODEL TYPE & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 MODEL TYPE
    • 6.2.1 INBRED MICE
      • 6.2.1.1 High utilization across research applications to propel market
    • 6.2.2 GENETICALLY ENGINEERED MICE
      • 6.2.2.1 Ability to induce mutations for CVD & cancer research to drive market
    • 6.2.3 HYBRID/CONGENIC MICE
      • 6.2.3.1 Growing focus on biomedical research to boost demand
    • 6.2.4 OUTBRED MICE
      • 6.2.4.1 Genetic diversity benefits to support market growth
  • 6.3 SERVICES
    • 6.3.1 BREEDING SERVICES
      • 6.3.1.1 Customization of models for specific research applications to boost demand
    • 6.3.2 CRYOPRESERVATION SERVICES
      • 6.3.2.1 Rising focus on preservation of novel mice models to propel market
    • 6.3.3 REDERIVATION SERVICES
      • 6.3.3.1 Stringent quality assurance standards to fuel market
    • 6.3.4 QUARANTINE SERVICES
      • 6.3.4.1 Rising demand for germ-free mice to support market growth
    • 6.3.5 OTHER SERVICES

7 MICE MODEL MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 CRISPR/CAS9
    • 7.2.1 ADVANTAGES SUCH AS SIMPLIFIED DESIGN AND COST EFFICIENCY TO PROPEL MARKET
  • 7.3 MICROINJECTIONS
    • 7.3.1 LOW TOXICITY AND HIGH SUCCESS RATE TO DRIVE MARKET
  • 7.4 EMBRYONIC STEM CELL INJECTIONS
    • 7.4.1 INCREASING DEMAND FOR TARGETED MICE MODELS IN IMMUNOLOGICAL RESEARCH TO FUEL MARKET
  • 7.5 NUCLEAR TRANSFER TECHNIQUE
    • 7.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET
  • 7.6 OTHER TECHNOLOGIES

8 MICE MODEL MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 DRUG DISCOVERY & DEVELOPMENT
    • 8.2.1 INCREASING NUMBER OF CLINICAL TRIALS TO PROPEL MARKET
  • 8.3 RESEARCH APPLICATIONS
    • 8.3.1 INCREASING FUNDING INVESTMENTS FOR CANCER RESEARCH TO DRIVE MARKET
  • 8.4 PERSONALIZED MEDICINE
    • 8.4.1 INCREASING PREFERENCE FOR ONCOLOGY THERAPEUTICS TO SUPPORT MARKET GROWTH

9 MICE MODEL MARKET, BY THERAPEUTIC AREA

  • 9.1 INTRODUCTION
  • 9.2 ONCOLOGY
    • 9.2.1 GROWING FOCUS ON THERAPEUTIC DEVELOPMENT TO PROPEL MARKET
  • 9.3 METABOLIC DISEASES
    • 9.3.1 INCREASING PREVALENCE OF ENDOCRINE DISORDERS TO DRIVE MARKET
  • 9.4 IMMUNOLOGY
    • 9.4.1 RISING CLINICAL RESEARCH ACTIVITIES FOR IMMUNOLOGICAL DISORDERS TO FUEL MARKET
  • 9.5 NEUROLOGY
    • 9.5.1 INCREASING INVESTMENTS IN R&D FOR CNS DISEASES TO BOOST DEMAND
  • 9.6 CARDIOVASCULAR DISEASES
    • 9.6.1 GROWING FOCUS ON TARGETED TREATMENTS FOR CVD TO BOOST DEMAND
  • 9.7 OTHER THERAPEUTIC AREAS

10 MICE MODEL TYPE MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO FUEL MARKET
  • 10.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CROS & CDMOS)
    • 10.3.1 INCREASING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET
  • 10.4 ACADEMIC & RESEARCH INSTITUTES
    • 10.4.1 INCREASING FUNDING INITIATIVES FOR LIFE SCIENCES R&D TO SUPPORT MARKET GROWTH

11 MICE MODEL SERVICES MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.2.1 RISING OUTSOURCING OF PRECLINICAL SERVICES TO PROPEL MARKET
  • 11.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS)
    • 11.3.1 DEVELOPMENT OF INTEGRATED MODELS AND GROWTH IN BIOLOGICS TO BOOST DEMAND
  • 11.4 GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES
    • 11.4.1 FOCUS ON TRANSLATIONAL RESEARCH SERVICES TO SUPPORT MARKET GROWTH

12 MICE MODEL MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 Rising production of monoclonal antibodies to fuel market
    • 12.2.3 CANADA
      • 12.2.3.1 Growth in stem cell research activities to fuel market
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Growth in biotechnology industry to drive market
    • 12.3.3 UK
      • 12.3.3.1 Increasing focus on cancer research to propel market
    • 12.3.4 FRANCE
      • 12.3.4.1 Rising investments in proteomics & genomics research to boost demand
    • 12.3.5 ITALY
      • 12.3.5.1 Growth in pharmaceutical & biotechnology industry to drive market
    • 12.3.6 SPAIN
      • 12.3.6.1 Extensive R&D pipeline to fuel uptake
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Favorable investments in life sciences research to drive market
    • 12.4.3 JAPAN
      • 12.4.3.1 Increasing focus on personalized diagnostics products to drive market
    • 12.4.4 INDIA
      • 12.4.4.1 Favorable initiatives for drug discovery & development to boost market
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 High number of research institutes to favor market growth
    • 12.4.6 SOUTH KOREA
      • 12.4.6.1 Innovation in health & biotech sectors to support market uptake
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Increasing investments in biopharmaceutical research to fuel uptake
    • 12.5.3 MEXICO
      • 12.5.3.1 Expanding healthcare ecosystem to support market growth
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    • 12.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Kingdom of Saudi Arabia (KSA)
        • 12.6.2.1.1 Growing focus on advancement of healthcare sector to boost market
      • 12.6.2.2 United Arab Emirates
        • 12.6.2.2.1 Increasing R&D activities and growing demand for personalized medicine to propel market
      • 12.6.2.3 Other GCC Countries
    • 12.6.3 REST OF MIDDLE EAST
  • 12.7 AFRICA
    • 12.7.1 RISING PRECISION MEDICINE INITIATIVES TO SUPPORT MARKET GROWTH
    • 12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • 13.2.1 STRATEGIES ADOPTED BY KEY PLAYERS IN MICE MODEL MARKET, 2022-2025
  • 13.3 REVENUE SHARE ANALYSIS, 2022-2024
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Model type & service footprint
      • 13.5.5.4 Application footprint
      • 13.5.5.5 Technology footprint
      • 13.5.5.6 Therapeutic area footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 13.6.5.1 Detailed list of key startups/SME players
      • 13.6.5.2 Competitive benchmarking of key startups/SMEs
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
    • 13.7.1 FINANCIAL METRICS
    • 13.7.2 COMPANY VALUATION
  • 13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
    • 13.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS FOR MICE MODEL MARKET
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT/SERVICE LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 CHARLES RIVER LABORATORIES
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Deals
        • 14.1.1.3.2 Expansions
        • 14.1.1.3.3 Other developments
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 THE JACKSON LABORATORY
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
        • 14.1.2.3.2 Expansions
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses & competitive threats
    • 14.1.3 INOTIV
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Deals
        • 14.1.3.3.2 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses & competitive threats
    • 14.1.4 JSR CORPORATION
      • 14.1.4.1 Business overview
      • 14.1.4.2 Product/Services offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Deals
        • 14.1.4.3.2 Expansions
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Key strengths
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses & competitive threats
    • 14.1.5 BIOCYTOGEN
      • 14.1.5.1 Business overview
      • 14.1.5.2 Product/Services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Product/Service launches
        • 14.1.5.3.2 Deals
        • 14.1.5.3.3 Expansions
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strengths
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses & competitive threats
    • 14.1.6 SHANGHAI MODEL ORGANISMS CENTER, INC.
      • 14.1.6.1 Business overview
      • 14.1.6.2 Product/Services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Deals
    • 14.1.7 TRANS GENIC INC.
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
    • 14.1.8 HARBOUR BIOMED
      • 14.1.8.1 Business overview
      • 14.1.8.2 Product/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Deals
        • 14.1.8.3.2 Other developments
    • 14.1.9 GENOWAY
      • 14.1.9.1 Business overview
      • 14.1.9.2 Product/Services offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
    • 14.1.10 GEMPHARMATECH
      • 14.1.10.1 Business overview
      • 14.1.10.2 Product/Services offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Product/Service launches
        • 14.1.10.3.2 Deals
        • 14.1.10.3.3 Expansions
    • 14.1.11 CYAGEN
      • 14.1.11.1 Business overview
      • 14.1.11.2 Product/Services offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Deals
    • 14.1.12 OZGENE PTY LTD.
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products/Services offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Deals
    • 14.1.13 TACONIC BIOSCIENCES, INC.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products/Services offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Product/Service launches
        • 14.1.13.3.2 Deals
        • 14.1.13.3.3 Expansions
    • 14.1.14 TRANSCURE BIOSERVICES
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products/Services offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Deals
    • 14.1.15 VIVO BIO TECH LTD.
      • 14.1.15.1 Business overview
      • 14.1.15.2 Product/Services offered
    • 14.1.16 INGENIOUS TARGETING LABORATORY
      • 14.1.16.1 Business overview
      • 14.1.16.2 Product/Services offered
    • 14.1.17 JANVIER LABS
      • 14.1.17.1 Business overview
      • 14.1.17.2 Product/Services offered
      • 14.1.17.3 Recent developments
        • 14.1.17.3.1 Deals
    • 14.1.18 CHAMPIONS ONCOLOGY, INC.
      • 14.1.18.1 Business overview
      • 14.1.18.2 Products offered
      • 14.1.18.3 Recent developments
        • 14.1.18.3.1 Deals
    • 14.1.19 VITALSTAR BIOTECHNOLOGY CO., LTD.
      • 14.1.19.1 Business overview
      • 14.1.19.2 Products offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 ONCODESIGN SERVICES
    • 14.2.2 CLEA JAPAN, INC.
    • 14.2.3 APPLIED STEMCELL
    • 14.2.4 CREATIVE ANIMODEL
    • 14.2.5 JOINN LABORATORIES (CHINA) CO., LTD.
    • 14.2.6 CREATIVE BIOLABS
    • 14.2.7 CRESCENDO BIOLOGICS LIMITED
    • 14.2.8 ARAGEN LIFE SCIENCES LTD.
    • 14.2.9 POLYGENE
    • 14.2.10 PHARMTEST SERVICES
    • 14.2.11 MARSHALL BIORESOURCES

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
Show more
Product Code: BT 2192

List of Tables

  • TABLE 1 MICE MODEL MARKET: IMPACT ANALYSIS
  • TABLE 2 MICE MODEL MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 MICE MODEL MARKET: IMPACT ANALYSIS
  • TABLE 4 AVERAGE SELLING PRICE TREND OF MODEL TYPES, BY KEY PLAYER, 20222-2024
  • TABLE 5 AVERAGE SELLING PRICE OF MODEL TYPES, BY REGION, 2024
  • TABLE 6 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY VENDORS
  • TABLE 7 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR
  • TABLE 8 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY END USER
  • TABLE 9 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION
  • TABLE 10 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 11 PATENTS IN MICE MODELS MARKET
  • TABLE 12 IMPORT VALUE OF HS CODE 106.19.90-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSANDS)
  • TABLE 13 IMPORT VALUE OF HS CODE 106.19.90-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSANDS)
  • TABLE 14 MICE MODEL MARKET: CONFERENCES & EVENTS (2025-2026)
  • TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MICE MODEL MARKET: REGULATORY SCENARIO
  • TABLE 20 MICE MODEL MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 21 INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER, 2022-2025
  • TABLE 22 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 23 KEY PRODUCT-RELATED TARIFFS: LIVE ANIMALS, PRODUCT OF ANIMAL ORIGIN, AND MISCELLANEOUS CHEMICAL PRODUCTS
  • TABLE 24 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
  • TABLE 25 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 26 MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 34 INBRED MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 MIDDLE EAST: INBRED MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 40 GCC COUNTRIES: INBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 LATIN AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 MIDDLE EAST: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 GCC COUNTRIES: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 LATIN AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 MIDDLE EAST: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 GCC COUNTRIES: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 OUTBRED MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 LATIN AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 MIDDLE EAST: OUTBRED MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 GCC COUNTRIES: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 MICE MODEL SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 MICE MODEL SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 71 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 82 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2023-2030 (USD MILLION)
  • TABLE 83 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 92 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 95 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 97 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 MICE MODEL MARKET FOR OTHER SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 EUROPE: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 LATIN AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 MIDDLE EAST: MICE MODEL MARKET FOR OTHER SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 104 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 106 MICE MODEL MARKET FOR CRISPR/CAS9, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 107 NORTH AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 108 EUROPE: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 LATIN AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 MIDDLE EAST: MICE MODEL MARKET FOR CRISPR/CAS9, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 112 GCC COUNTRIES: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 MICE MODEL MARKET FOR MICROINJECTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 EUROPE: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 MIDDLE EAST: MICE MODEL MARKET FOR MICROINJECTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 119 GCC COUNTRIES: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 120 MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 EUROPE: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: MICE MODELS MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 MIDDLE EAST: MICE MODELS MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: MICE MODELS MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 128 NORTH AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 EUROPE: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 LATIN AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 132 MIDDLE EAST: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 133 GCC COUNTRIES: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 134 MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 135 NORTH AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 EUROPE: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 LATIN AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 139 MIDDLE EAST: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 140 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 142 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 146 LATIN AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 147 MIDDLE EAST: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 148 GCC COUNTRIES: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 150 NORTH AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 151 EUROPE: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 153 LATIN AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 154 MIDDLE EAST: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 157 NORTH AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 158 EUROPE: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 160 LATIN AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 161 MIDDLE EAST: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 162 GCC COUNTRIES: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 163 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 164 MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 165 NORTH AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 166 EUROPE: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST: MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 170 GCC COUNTRIES: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 171 MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 EUROPE: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 LATIN AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST: MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 177 GCC COUNTRIES: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 178 MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 179 NORTH AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 EUROPE: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 182 LATIN AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 183 MIDDLE EAST: MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 184 GCC COUNTRIES: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 185 MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 186 NORTH AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 EUROPE: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 190 MIDDLE EAST: MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 191 GCC COUNTRIES: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 192 MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 193 NORTH AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 194 EUROPE: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 196 LATIN AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 197 MIDDLE EAST: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 198 GCC COUNTRIES: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 199 MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 200 NORTH AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 201 EUROPE: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 204 MIDDLE EAST: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 206 MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 207 MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 208 NORTH AMERICA: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 209 EUROPE: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 211 LATIN AMERICA: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 212 MIDDLE EAST: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 213 GCC COUNTRIES: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 214 MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 215 NORTH AMERICA: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 216 EUROPE: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 218 LATIN AMERICA: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 USD MILLION)
  • TABLE 219 MIDDLE EAST: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 221 MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 222 NORTH AMERICA: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 223 EUROPE: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 225 LATIN AMERICA: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 226 MIDDLE EAST: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 228 MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 229 MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 230 NORTH AMERICA: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 231 EUROPE: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 232 ASIA PACIFIC: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 233 LATIN AMERICA: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 236 MICE MODEL SERVICES MARKET FOR CDMOS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 237 NORTH AMERICA: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 238 EUROPE: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 240 LATIN AMERICA: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023-2030 USD MILLION)
  • TABLE 241 MIDDLE EAST: MICE MODEL SERVICES MARKET FOR CDMOS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 243 MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 244 NORTH AMERICA: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 245 EUROPE: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 247 LATIN AMERICA: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 248 MIDDLE EAST: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 249 GCC COUNTRIES: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 250 MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 251 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 252 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 253 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 254 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 256 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 257 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 258 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 259 NORTH AMERICA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 260 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 261 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 262 US: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 US: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 264 US: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 265 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 266 US: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 267 US: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 268 US: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 269 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 270 CANADA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 CANADA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 272 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 273 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 274 CANADA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 275 CANADA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 276 CANADA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 277 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 278 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 279 EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 280 EUROPE: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 281 EUROPE: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 282 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 283 EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 284 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 285 EUROPE: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 286 EUROPE: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 287 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 288 GERMANY: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 GERMANY: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 290 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 291 GERMANY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 292 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 293 GERMANY: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 294 GERMANY: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 295 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 296 UK: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 297 UK: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 298 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 299 UK: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 300 UK: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 301 UK: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 302 UK: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 303 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 304 FRANCE: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 305 FRANCE: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 306 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 307 FRANCE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 308 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 309 FRANCE: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 310 FRANCE: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 311 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 312 ITALY: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 ITALY: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 314 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 315 ITALY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 316 ITALY: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 317 ITALY: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 318 ITALY: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 319 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 320 SPAIN: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 321 SPAIN: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 322 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 323 SPAIN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 324 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 325 SPAIN: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 326 SPAIN: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 327 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 328 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 330 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 331 REST OF EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 332 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 333 REST OF EUROPE: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 334 REST OF EUROPE: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 335 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 336 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 338 ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 340 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 341 ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 342 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 345 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 346 CHINA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 347 CHINA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 348 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 349 CHINA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 350 CHINA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 351 CHINA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 352 CHINA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 353 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 354 JAPAN: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 355 JAPAN: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 356 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 357 JAPAN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 358 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 359 JAPAN: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 360 JAPAN: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 361 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 362 INDIA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 363 INDIA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 364 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 365 INDIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 366 INDIA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 367 INDIA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 368 INDIA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 369 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 370 AUSTRALIA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 371 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 372 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 373 AUSTRALIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 374 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 375 AUSTRALIA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 376 AUSTRALIA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 377 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 378 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 379 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 380 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 381 SOUTH KOREA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 382 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 383 SOUTH KOREA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 384 SOUTH KOREA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 385 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 386 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 387 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 388 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 389 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 390 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 391 REST OF ASIA PACIFIC: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 392 REST OF ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 393 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 394 LATIN AMERICA: MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 395 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 396 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 397 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 398 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 399 LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 400 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 401 LATIN AMERICA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 402 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 403 BRAZIL: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 404 BRAZIL: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 405 BRAZIL: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 406 BRAZIL: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 407 BRAZIL: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 408 BRAZIL: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 409 BRAZIL: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 410 BRAZIL: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 411 MEXICO: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 412 MEXICO: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 413 MEXICO: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 414 MEXICO: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 415 MEXICO: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 416 MEXICO: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 417 MEXICO: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 418 MEXICO: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION
  • TABLE 419 REST OF LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 420 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 421 REST OF LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 422 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 423 REST OF LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 424 REST OF LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 425 REST OF LATIN AMERICA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 426 REST OF LATIN AMERICA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 427 MIDDLE EAST: MACROECONOMIC INDICATORS
  • TABLE 428 MIDDLE EAST: MICE MODEL MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 429 MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 430 MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 431 MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 432 MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 433 MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 434 MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 435 MIDDLE EAST: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 436 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 437 GCC COUNTRIES: MICE MODEL MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 438 GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 439 GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 440 GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 441 GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 442 GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 443 GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 444 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 445 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 446 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 447 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 448 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 449 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 450 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 451 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 452 KINGDOM OF SAUDI ARABIA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 453 KINGDOM OF SAUDI ARABIA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 454 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 455 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 456 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 457 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 458 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 459 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 460 UNITED ARAB EMIRATES: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 461 UNITED ARAB EMIRATES: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 462 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 463 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 464 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 465 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 466 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 467 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 468 OTHER GCC COUNTRIES: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 469 OTHER GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 470 REST OF MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 471 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 472 REST OF MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 473 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 474 REST OF MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 475 REST OF MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 476 REST OF MIDDLE EAST: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 477 REST OF MIDDLE EAST: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 478 MACROECONOMIC OUTLOOK FOR AFRICA
  • TABLE 479 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 480 AFRICA: MICE MODEL MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 481 AFRICA: MICE MODEL MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 482 AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 483 AFRICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
  • TABLE 484 AFRICA: MICE MODEL MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 485 AFRICA: MICE MODEL TYPE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 486 AFRICA: MICE MODEL SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 487 STRATEGIES ADOPTED BY KEY PLAYERS IN MICE MODEL MARKET, 2022-2025
  • TABLE 488 MICE MODEL MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • TABLE 489 MICE MODEL MARKET: REGION FOOTPRINT
  • TABLE 490 MICE MODEL MARKET: MODEL TYPE & SERVICE FOOTPRINT
  • TABLE 491 MICE MODEL MARKET: APPLICATION FOOTPRINT
  • TABLE 492 MICE MODEL MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 493 MICE MODEL MARKET: THERAPEUTIC AREA FOOTPRINT
  • TABLE 494 MICE MODEL MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 495 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 496 MICE MODEL MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 497 MICE MODEL MARKET: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 498 MICE MODEL MARKET: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 499 MICE MODEL MARKET: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
  • TABLE 500 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 501 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 502 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 503 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 504 CHARLES RIVER LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
  • TABLE 505 THE JACKSON LABORATORY: COMPANY OVERVIEW
  • TABLE 506 THE JACKSON LABORATORY: PRODUCTS/SERVICES OFFERED
  • TABLE 507 THE JACKSON LABORATORY: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 508 THE JACKSON LABORATORY: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 509 INOTIV: COMPANY OVERVIEW
  • TABLE 510 INOTIV: PRODUCTS/SERVICES OFFERED
  • TABLE 511 INOTIV: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 512 INOTIV: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 513 JSR CORPORATION: COMPANY OVERVIEW
  • TABLE 514 JSR CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 515 JSR CORPORATION: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 516 JSR CORPORATION: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 517 BIOCYTOGEN: COMPANY OVERVIEW
  • TABLE 518 BIOCYTOGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 519 BIOCYTOGEN: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 520 BIOCYTOGEN: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 521 BIOCYTOGEN: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 522 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY OVERVIEW
  • TABLE 523 SHANGHAI MODEL ORGANISMS CENTER, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 524 SHANGHAI MODEL ORGANISMS CENTER, INC.: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 525 TRANS GENIC INC.: COMPANY OVERVIEW
  • TABLE 526 TRANS GENIC, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 527 TRANS GENIC, INC.: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 528 HARBOUR BIOMED: COMPANY OVERVIEW
  • TABLE 529 HARBOUR BIOMED: PRODUCTS/SERVICES OFFERED
  • TABLE 530 HARBOUR BIOMED: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 531 HARBOUR BIOMED: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
  • TABLE 532 GENOWAY: COMPANY OVERVIEW
  • TABLE 533 GENOWAY: PRODUCTS/SERVICES OFFERED
  • TABLE 534 GENOWAY: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 535 GEMPHARMATECH: COMPANY OVERVIEW
  • TABLE 536 GEMPHARMATECH: PRODUCTS/SERVICES OFFERED
  • TABLE 537 GEMPHARMATECH: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 538 GEMPHARMATECH: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 539 GEMPHARMATECH: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 540 CYAGEN: COMPANY OVERVIEW
  • TABLE 541 CYAGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 542 CYAGEN: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 543 OZGENE PTY LTD.: COMPANY OVERVIEW
  • TABLE 544 OZGENE PTY LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 545 OZGENE PTY. LTD: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 546 TACONIC BIOSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 547 TACONIC BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 548 TACONIC BIOSCIENCES, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 549 TACONIC BIOSCIENCES, INC.: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 550 TACONIC BIOSCIENCES, INC.: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 551 TRANSCURE BIOSERVICES: COMPANY OVERVIEW
  • TABLE 552 TRANSCURE BIOSERVICES: PRODUCTS/SERVICES OFFERED
  • TABLE 553 TRANSCURE BIOSERVICES: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 554 VIVO BIO TECH LTD.: COMPANY OVERVIEW
  • TABLE 555 VIVO BIO TECH LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 556 INGENIOUS TARGETING LABORATORY: COMPANY OVERVIEW
  • TABLE 557 INGENIOUS TARGETING LABORATORY: PRODUCTS/SERVICES OFFERED
  • TABLE 558 JANVIER LABS: COMPANY OVERVIEW
  • TABLE 559 JANVIER LABS: PRODUCTS/SERVICES OFFERED
  • TABLE 560 JANVIER LABS: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 561 CHAMPIONS ONCOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 562 CHAMPIONS ONCOLOGY, INC.: PRODUCTS OFFERED
  • TABLE 563 CHAMPIONS ONCOLOGY, INC.: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 564 VITALSTAR BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 565 VITALSTAR BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 566 ONCODESIGN SERVICES: COMPANY OVERVIEW
  • TABLE 567 CLEA JAPAN, INC.: COMPANY OVERVIEW
  • TABLE 568 APPLIED STEMCELL: COMPANY OVERVIEW
  • TABLE 569 CREATIVE ANIMODEL: COMPANY OVERVIEW
  • TABLE 570 JOINN LABORATORIES (CHINA) CO., LTD.: COMPANY OVERVIEW
  • TABLE 571 CREATIVE BIOLABS: COMPANY OVERVIEW
  • TABLE 572 CRESCENDO BIOLOGICS LIMITED: COMPANY OVERVIEW
  • TABLE 573 ARAGEN LIFE SCIENCES LTD.: BUSINESS OVERVIEW
  • TABLE 574 POLYGENE: BUSINESS OVERVIEW
  • TABLE 575 PHARMATEST: BUSINESS OVERVIEW
  • TABLE 576 MARSHALL BIORESOURCES: BUSINESS OVERVIEW

List of Figures

  • FIGURE 1 MICE MODEL MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 4 MICE MODEL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES: REVENUE SHARE ANALYSIS (2024)
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 MICE MODEL MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 MICE MODEL MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 MICE MODEL MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 GEOGRAPHIC SNAPSHOT OF MICE MODEL MARKET
  • FIGURE 16 RISING DEMAND FOR MOUSE CLINICAL TRIALS TO PROPEL MARKET
  • FIGURE 17 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 MICE MODEL MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 23 AVERAGE SELLING PRICE TREND OF MODEL TYPES, BY KEY PLAYER, 2022-2024 (USD)
  • FIGURE 24 AVERAGE SELLING PRICE OF MODEL TYPES, BY REGION (USD)
  • FIGURE 25 MICE MODEL MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 PATENT APPLICATIONS IN MICE MODEL MARKET, JANUARY 2014-DECEMBER 2024
  • FIGURE 28 MICE MODEL MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICE MODEL MARKET
  • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 31 INVESTMENT & FUNDING SCENARIO, 2022-2025
  • FIGURE 32 AI-USE CASES IN MICE MODEL MARKET
  • FIGURE 33 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
  • FIGURE 34 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT
  • FIGURE 35 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2022-2024 (USD MILLION)
  • FIGURE 36 MICE MODEL MARKET SHARE ANALYSIS OF KEY PLAYERS (2024)
  • FIGURE 37 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS) 2024,
  • FIGURE 38 MICE MODEL MARKET: COMPANY FOOTPRINT
  • FIGURE 39 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 42 MICE MODEL MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 43 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 44 THE JACKSON LABORATORY: COMPANY SNAPSHOT (2024)
  • FIGURE 45 INOTIV: COMPANY SNAPSHOT (2024)
  • FIGURE 46 JSR CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 BIOCYTOGEN: COMPANY SNAPSHOT (2024)
  • FIGURE 48 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 49 TRANS GENIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 50 HARBOUR BIOMED: COMPANY SNAPSHOT (2024)
  • FIGURE 51 GENOWAY: COMPANY SNAPSHOT (2024)
  • FIGURE 52 GEMPHARMATECH: COMPANY SNAPSHOT (2024)
  • FIGURE 53 VIVO BIO TECH LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 CHAMPIONS ONCOLOGY, INC.: COMPANY SNAPSHOT (2023)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!